Bristol Myers Squibb results top expectations as newer drugs help fuel growth

Bristol Myers Squibb on Friday reported fourth-quarter results that beat analysts’ expectations, helped by portfolio stalwarts as well as newer drugs.

Previous post Push for AI sovereignty will see growth of tech sectors in ‘every single country’ worldwide, Nvidia CEO Jensen Huang says
Next post Cigna’s stock leaps toward a 13-month high after earnings beat, raised dividend